Series B - Slayback Pharma
Investment Firm
Overview
Slayback Pharma believe every pharmaceutical product exhibits its own unique personality.
Announced Date
Jan 06, 2020
Funding Type
Series B
Highlights
Location
United States, North America
Social
Participant Investors
1
| Investor Name |
|---|
 Everstone |
Round Details and Background
Slayback Pharma raised $50000000 on 2020-01-06 in Series B
Slayback Pharma believe every pharmaceutical product exhibits its own unique personality.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jan 06, 2020 |  Series B - Slayback Pharma | 1 | - | 50.0M |
| Jan 05, 2017 | Private Equity Round - Slayback Pharma | 1 | - | 60.0M |
Recent Activity
There is no recent news or activity for this profile.